QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
NASDAQ:NAOV

NanoVibronix (NAOV) Stock Forecast, Price & News

$0.72
+0.04 (+5.88%)
(As of 05/19/2022 04:00 PM ET)
Add
Compare
Today's Range
$0.68
$0.72
50-Day Range
$0.55
$1.19
52-Week Range
$0.48
$4.19
Volume
87,768 shs
Average Volume
1.08 million shs
Market Capitalization
$20.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.59
30 days | 90 days | 365 days | Advanced Chart
Receive NAOV News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter.

NanoVibronix logo

About NanoVibronix

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NAOV
Employees
11
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.70 million
Book Value
$0.23 per share

Profitability

Net Income
$-14.28 million
Net Margins
-842.60%
Pretax Margin
-840.71%

Debt

Price-To-Earnings

Miscellaneous

Free Float
26,850,000
Market Cap
$20.16 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/14/2018
Today
5/19/2022
Next Earnings (Estimated)
8/15/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

0.77 out of 5 stars

Medical Sector

1303rd out of 1,418 stocks

Surgical Appliances & Supplies Industry

26th out of 29 stocks

Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













NanoVibronix (NASDAQ:NAOV) Frequently Asked Questions

Are investors shorting NanoVibronix?

NanoVibronix saw a decrease in short interest in April. As of April 30th, there was short interest totaling 416,000 shares, a decrease of 40.9% from the April 15th total of 703,600 shares. Based on an average daily trading volume, of 1,450,000 shares, the days-to-cover ratio is currently 0.3 days.
View NanoVibronix's Short Interest
.

When is NanoVibronix's next earnings date?

NanoVibronix is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022.
View our earnings forecast for NanoVibronix
.

How were NanoVibronix's earnings last quarter?

NanoVibronix, Inc. (NASDAQ:NAOV) issued its earnings results on Wednesday, November, 14th. The company reported ($0.21) earnings per share for the quarter. The company had revenue of $0.05 million for the quarter. NanoVibronix had a negative trailing twelve-month return on equity of 179.15% and a negative net margin of 842.60%.
View NanoVibronix's earnings history
.

Who are NanoVibronix's key executives?
NanoVibronix's management team includes the following people:
  • Mr. Brian M. Murphy, CEO & Director (Age 65, Pay $321k)
  • Mr. Stephen R. Brown CPA, CPA, CFO & Accounting Officer (Age 66, Pay $207.5k)
  • Mr. Amir Rippel, VP of Marketing
  • Mrs. Lindsey Harrison, VP of Sales
  • Dr. Harold Jacob M.D., Chief Medical Officer & Director (Age 68)
What other stocks do shareholders of NanoVibronix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), (CGC), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), BIO-key International (BKYI), Digital Ally (DGLY), iBio (IBIO) and Inpixon (INPX).

What is NanoVibronix's stock symbol?

NanoVibronix trades on the NASDAQ under the ticker symbol "NAOV."

Who are NanoVibronix's major shareholders?

NanoVibronix's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (2.33%), Renaissance Technologies LLC (1.05%) and State Street Corp (0.45%).
View institutional ownership trends for NanoVibronix
.

Which major investors are selling NanoVibronix stock?

NAOV stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.
View insider buying and selling activity for NanoVibronix
or view top insider-selling stocks.

Which major investors are buying NanoVibronix stock?

NAOV stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., and State Street Corp.
View insider buying and selling activity for NanoVibronix
or or view top insider-buying stocks.

How do I buy shares of NanoVibronix?

Shares of NAOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoVibronix's stock price today?

One share of NAOV stock can currently be purchased for approximately $0.72.

How much money does NanoVibronix make?

NanoVibronix has a market capitalization of $20.16 million and generates $1.70 million in revenue each year.

How many employees does NanoVibronix have?

NanoVibronix employs 11 workers across the globe.

What is NanoVibronix's official website?

The official website for NanoVibronix is www.nanovibronix.com.

How can I contact NanoVibronix?

NanoVibronix's mailing address is 525 Executive Blvd, Elmsford NY, 10523. The company can be reached via phone at (914) 233-3004, via email at [email protected], or via fax at 914-376-6111.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.